Pain analysis from the phase III randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) with bone metastases.
Sten Nilsson
Consultant or Advisory Role - Algeta
A. Oliver Sartor
Consultant or Advisory Role - Algeta; Bayer
Oyvind S. Bruland
Consultant or Advisory Role - Algeta
Stock Ownership - Algeta
Honoraria - Algeta
Fang Fang
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Paul Cislo
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Anne-Kirsti Aksnes
Employment or Leadership Position - Algeta
Stock Ownership - Algeta
Chris Parker
Consultant or Advisory Role - Algeta (U); Bayer